[Close]  
Pharmaceutical market research logo; 24-years of Excellence in Market Research since 1988 roundel.

Need advice? Keen to get the best deal? Call now on +44 (0)1494 771734

>

Skin Infections and Dermatosis Therapy Pipeline Report

Skin Infections and Dermatosis Therapy Pipeline Report

Table of Contents

Market Briefing
Published: January 2011
Pages: 774
Tables: For full details, please email deborahf@cmsinfo.com
From: GBP 934.38  Buy Now!
Research from: pharmaceuticalmarketresearch
Sector: Indication Areas

Life Science Analytics', Skin Infections and Dermatosis Therapy Area Pipeline Report contains detailed information on the skin infections and dermatosis therapy pipeline reports drug pipeline. This report provides insight into the pipeline status of skin infections and dermatosis therapy pipeline reports drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

• Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
• Keep track of your competitors and partners by better understanding their product pipeline.
• Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
• Maintain a critical competitive advantage.

Top of Page